Except for previous data on GD, our study is the first to underline the relatively high prevalence of MM in PD patients harboring heterozygous GBA mutations (without systemic GD involvement) and notably in asymptomatic GBA mutation carriers. This evidence concerns the gene GBA1 and Parkinson disease.